116 related articles for article (PubMed ID: 21624414)
21. Application of liposomes for development of oral vaccines: study of in vitro stability of liposomes and antibody response to antigen associated with liposomes after oral immunization.
Han M; Watarai S; Kobayashi K; Yasuda T
J Vet Med Sci; 1997 Dec; 59(12):1109-14. PubMed ID: 9450240
[TBL] [Abstract][Full Text] [Related]
22. Induction and detection of antibodies to squalene.
Matyas GR; Wassef NM; Rao M; Alving CR
J Immunol Methods; 2000 Nov; 245(1-2):1-14. PubMed ID: 11042279
[TBL] [Abstract][Full Text] [Related]
23. Antibodies reactive with liposomal phospholipids are produced during experimental Trypanosoma rhodesiense infections in rabbits.
Richards RL; Aronson J; Schoenbechler M; Diggs CL; Alving CR
J Immunol; 1983 Mar; 130(3):1390-4. PubMed ID: 6185580
[TBL] [Abstract][Full Text] [Related]
24. Attachment of monophosphoryl lipid A (MPL) to cells and liposomes augments antibody response to membrane-bound gangliosides.
Ravindranath MH; Morton DL; Irie RF
J Autoimmun; 1994 Dec; 7(6):803-16. PubMed ID: 7888037
[TBL] [Abstract][Full Text] [Related]
25. Prostaglandin and thromboxane in liposomes: suppression of the primary immune response to liposomal antigens.
Wassef NM; Richards RL; Hayre MD; Alving CR
Biochem Biophys Res Commun; 1989 Apr; 160(2):565-72. PubMed ID: 2719681
[TBL] [Abstract][Full Text] [Related]
26. Murine IgG subclass antibodies to antigens incorporated in liposomes containing lipid A.
Glenn GM; Rao M; Richards RL; Matyas GR; Alving CR
Immunol Lett; 1995; 47(1-2):73-8. PubMed ID: 8537104
[TBL] [Abstract][Full Text] [Related]
27. Antibody response in the intestinal tract of mice orally immunized with antigen associated with liposomes.
Watarai S; Han M; Tana ; Kodama H
J Vet Med Sci; 1998 Sep; 60(9):1047-50. PubMed ID: 9795911
[TBL] [Abstract][Full Text] [Related]
28. Monoclonal antibodies to phosphatidylinositol phosphate neutralize human immunodeficiency virus type 1: role of phosphate-binding subsites.
Brown BK; Karasavvas N; Beck Z; Matyas GR; Birx DL; Polonis VR; Alving CR
J Virol; 2007 Feb; 81(4):2087-91. PubMed ID: 17151131
[TBL] [Abstract][Full Text] [Related]
29. Safety of archaeosome adjuvants evaluated in a mouse model.
Patel GB; Omri A; Deschatelets L; Sprott GD
J Liposome Res; 2002 Nov; 12(4):353-72. PubMed ID: 12519630
[TBL] [Abstract][Full Text] [Related]
30. In vivo evidence of oral vaccination with PLGA nanoparticles containing the immunostimulant monophosphoryl lipid A.
Sarti F; Perera G; Hintzen F; Kotti K; Karageorgiou V; Kammona O; Kiparissides C; Bernkop-Schnürch A
Biomaterials; 2011 Jun; 32(16):4052-7. PubMed ID: 21377204
[TBL] [Abstract][Full Text] [Related]
31. Differences in avidity of IgG antibodies to pertussis toxin after acellular pertussis booster vaccination and natural infection.
Barkoff AM; Gröndahl-Yli-Hannuksela K; Vuononvirta J; Mertsola J; Kallonen T; He Q
Vaccine; 2012 Nov; 30(48):6897-902. PubMed ID: 22981763
[TBL] [Abstract][Full Text] [Related]
32. Immunoglobulin immobilized liposomal constructs for transmucosal vaccination through nasal route.
Tiwari B; Agarwal A; Kharya AK; Lariya N; Saraogi G; Agrawal H; Agrawal GP
J Liposome Res; 2011 Sep; 21(3):181-93. PubMed ID: 20626315
[TBL] [Abstract][Full Text] [Related]
33. Archaeosomes with encapsulated antigens for oral vaccine delivery.
Li Z; Zhang L; Sun W; Ding Q; Hou Y; Xu Y
Vaccine; 2011 Jul; 29(32):5260-6. PubMed ID: 21609747
[TBL] [Abstract][Full Text] [Related]
34. Development of an anti-Salmonella typhi Vi ELISA: assessment of immunocompetence in healthy donors.
Ferry BL; Misbah SA; Stephens P; Sherrell Z; Lythgoe H; Bateman E; Banner C; Jones J; Groome N; Chapel HM
Clin Exp Immunol; 2004 May; 136(2):297-303. PubMed ID: 15086394
[TBL] [Abstract][Full Text] [Related]
35. HIV-1, lipid rafts, and antibodies to liposomes: implications for anti-viral-neutralizing antibodies.
Alving CR; Beck Z; Karasavva N; Matyas GR; Rao M
Mol Membr Biol; 2006; 23(6):453-65. PubMed ID: 17127618
[TBL] [Abstract][Full Text] [Related]
36. Novel IgE peptide-based vaccine prevents the increase of IgE and down-regulates elevated IgE in rodents.
Peng Z; Liu Q; Wang Q; Rector E; Ma Y; Warrington R
Clin Exp Allergy; 2007 Jul; 37(7):1040-8. PubMed ID: 17581197
[TBL] [Abstract][Full Text] [Related]
37. Haptenic activity of galactosyl ceramide and its topographical distribution on liposomal membranes. I. Effect of cholesterol incorporation.
Suzuki T; Utsumi H; Inoue K; Nojima S
Biochim Biophys Acta; 1981 Jun; 644(2):183-91. PubMed ID: 6266467
[TBL] [Abstract][Full Text] [Related]
38. Interaction of antibody-bearing small unilamellar liposomes with antigen-coated cells. The effect of antibody and antigen concentration on the liposomal and cell surface respectively.
Gregoriadis G; Meehan A
Biochem J; 1981 Nov; 200(2):211-6. PubMed ID: 6176223
[TBL] [Abstract][Full Text] [Related]
39. Immunization with recombinant Opc outer membrane protein from Neisseria meningitidis: influence of sequence variation and levels of expression on the bactericidal immune response against meningococci.
Jolley KA; Appleby L; Wright JC; Christodoulides M; Heckels JE
Infect Immun; 2001 Jun; 69(6):3809-16. PubMed ID: 11349046
[TBL] [Abstract][Full Text] [Related]
40. Bordetella pertussis monophosphoryl lipid A as adjuvant for inactivated split virion influenza vaccine in mice.
Quintilio W; Kubrusly FS; Iourtov D; Miyaki C; Sakauchi MA; Lúcio F; Dias Sde C; Takata CS; Miyaji EN; Higashi HG; Leite LC; Raw I
Vaccine; 2009 Jun; 27(31):4219-24. PubMed ID: 19393709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
